
The discussion offers only broad themes in autonomous driving and oncology, with no named companies, tickers, valuations, or timelines. It does not support a specific actionable investment recommendation; monitor regulatory developments in autonomous vehicles and advances in cancer treatment before considering exposure.

By @iltb_podcast
Conversations with the best investors and business leaders in the world. We explore their ideas, methods, and stories to help you ...